What Is a PSA Test? Normal Levels by Age, Accuracy, and Next Steps

"Learn what a PSA blood test measures, how levels may vary by age, how accurate the test is, and what to do if your PSA result is high."

EDITOR EA October 10, 2026

A doctor performs a prostate ultrasound examination on a male patient in a urology clinic.

Illustration of a man undergoing a prostate ultrasound examination with a physician in a urology clinic.

A prostate-specific antigen (PSA) test is a blood test that measures a protein produced by the prostate gland. Doctors use it to help assess prostate cancer risk, decide whether further testing may be needed, and monitor some men who have already been diagnosed with prostate cancer.

A PSA test is commonly used in prostate cancer screening, but it cannot diagnose cancer on its own. An elevated result may be caused by prostate cancer, an enlarged prostate, inflammation, infection, or other factors. Conversely, some men with prostate cancer have PSA levels that are not unusually high.

There is no single PSA level that is considered normal for every man. Age, prostate size, medications, previous test results, family history, and other clinical factors can all affect how a result should be interpreted.

This guide explains what a PSA test measures, how doctors interpret PSA levels by age, how accurate the test is, and what to do if your result is higher than expected.

What Is a PSA Test?

PSA stands for prostate-specific antigen, a protein produced by cells in the prostate gland. A small amount normally circulates in the blood.

The PSA blood test measures the concentration of this protein in nanograms per milliliter (ng/mL).

Doctors may use PSA testing for several purposes:

Screening: Helping assess the possibility of prostate cancer in men without symptoms.
Diagnostic evaluation: Providing additional information when symptoms or other findings raise concern about prostate cancer.
Treatment planning: Helping assess disease risk when prostate cancer has been diagnosed.
Monitoring: Tracking the response to treatment or watching for signs that cancer may have returned.

A PSA test is not the same as a prostate biopsy. It measures a blood marker; a biopsy collects tissue for examination to determine whether cancer is present.

The National Cancer Institute explains that PSA can be elevated in men with prostate cancer as well as in men with noncancerous prostate conditions.

What Is a Normal PSA Level by Age?

PSA levels generally increase as men get older, partly because the prostate often grows with age. However, age-specific PSA ranges are not universally accepted diagnostic standards, and medical organizations do not recommend treating a single age-based cutoff as definitive.

The following figures illustrate age-specific thresholds that have been discussed in clinical research and guidelines. They are not universal definitions of a normal PSA result.

Age	Example of an age-specific PSA threshold
In your 40s	2.5 ng/mL
In your 50s	3.5 ng/mL
In your 60s	4.5 ng/mL
In your 70s	6.5 ng/mL

These values have been described in American Urological Association/Society of Urologic Oncology guidance as examples of thresholds used in some studies. They should not be interpreted as automatic biopsy triggers or proof that a result below the threshold is safe.

For example, a PSA of 3.2 ng/mL might be interpreted differently in a younger man than in an older man. But age alone does not determine whether the result is concerning. A clinician may consider the patient's previous PSA measurements, family history, prostate size, medications, and other risk factors.

Is a PSA level below 4 normal?

A PSA below 4 ng/mL is often considered reassuring in some clinical contexts, but it does not rule out prostate cancer.

The American Cancer Society reports that some men with PSA levels below 4 ng/mL are found to have prostate cancer on biopsy. It also notes that the likelihood of cancer generally increases as PSA rises, although benign conditions can also produce elevated results.

Is a PSA level above 4 always cancer?

No. A PSA above 4 ng/mL does not automatically mean cancer is present.

An enlarged prostate, prostatitis, urinary infection, and other factors can increase PSA. Some clinicians may recommend further evaluation at levels below 4 ng/mL, depending on the patient's risk and clinical circumstances.

The key is to interpret the result in context rather than relying on one cutoff.

What Do Different PSA Levels Mean?

PSA results are best understood as part of an overall risk assessment, not as a diagnosis by themselves.

The American Cancer Society provides the following general estimates for men undergoing evaluation:

PSA result	General interpretation
Below 4 ng/mL	Often considered lower risk, but cancer is still possible
4–10 ng/mL	Sometimes called the borderline range; approximately 1 in 4 men in this range may have prostate cancer
Above 10 ng/mL	The likelihood of prostate cancer is higher; the ACS reports a probability above 50%

These are broad estimates, not personalized predictions. The likelihood of cancer in an individual depends on age, symptoms, prostate size, family history, previous results, and other clinical information. Some cancers detected in men with elevated PSA are slow-growing and may not require immediate treatment.

A high PSA should prompt a discussion about appropriate next steps, not an assumption that cancer has been confirmed.

How Accurate Is a PSA Test?

A PSA test can help identify men who may need further evaluation, but it has important limitations.

False-positive results

A false-positive result occurs when the PSA level is elevated but the patient does not have prostate cancer.

Possible causes include:

Benign prostatic hyperplasia (BPH), or an enlarged prostate.
Prostatitis or inflammation of the prostate.
A urinary infection or other temporary medical issue.
Recent prostate procedures.
Ejaculation shortly before testing, which can temporarily raise PSA in some men.

False-positive results may lead to additional blood tests, imaging, anxiety, or a biopsy that ultimately does not find cancer.

False-negative results

A false-negative result occurs when the PSA test is not elevated even though prostate cancer is present.

A low PSA level cannot completely exclude cancer. This is why clinicians may consider symptoms, family history, examination findings, and other risk factors alongside the test result.

Does a higher PSA mean more aggressive cancer?

Not necessarily. PSA is associated with prostate cancer risk, but the level alone cannot determine how aggressive a tumor is.

If cancer is diagnosed, doctors consider additional information such as the biopsy's Grade Group, tumor stage, imaging findings, and other clinical factors to assess risk and select treatment.

The ACS emphasizes that PSA screening can produce both false-positive and false-negative results and that further evaluation may be needed when findings are abnormal.

What Can Affect Your PSA Level?

Several factors can influence a PSA result even when prostate cancer is not present.

Enlarged prostate

BPH is common as men age and can increase PSA because a larger prostate may produce more of the protein.

Prostate inflammation or infection

Prostatitis and urinary infections can raise PSA. Depending on the condition, a clinician may recommend treating the underlying problem and repeating the test after an appropriate interval.

Ejaculation

Ejaculation can temporarily increase PSA in some men. Some clinicians advise avoiding ejaculation for 24–48 hours before testing, particularly when a result needs careful interpretation.

Recent procedures

A prostate biopsy and some other urologic procedures can affect PSA levels for a period of time. Tell your healthcare provider about recent procedures before testing.

Medications

Finasteride and dutasteride, medicines commonly used for BPH, can lower PSA levels. Your clinician needs to know if you take either medicine because the result may require a different interpretation.

Do not stop prescribed medication just to prepare for a PSA test. Ask your healthcare provider whether any preparation is necessary.

The NCI and ACS describe these factors as important considerations when interpreting PSA results.

How Should You Prepare for a PSA Test?

A PSA test usually requires a blood sample and does not typically require fasting unless other tests being performed at the same time have different requirements.

Before the test:

Tell your healthcare provider about urinary symptoms, recent infections, and any prostate procedures.
Provide a list of medicines and supplements, especially finasteride or dutasteride.
Ask whether you should avoid ejaculation for 24–48 hours before testing.
Follow the laboratory's instructions and tell your clinician if you have recently had a procedure or urinary problem.
If you are repeating a PSA test, ask whether the timing should be adjusted to account for temporary factors.

Consistent testing conditions can make it easier to compare results over time.

What Should You Do If Your PSA Is High?

An elevated PSA result does not automatically require an immediate biopsy. In many cases, the next step is to confirm the result and assess the patient's overall risk.

Step 1: Review the result with your clinician

Ask how the PSA compares with your previous results, whether the elevation is substantial, and whether any temporary factor could explain it.

Your age, family history, symptoms, medications, and prostate size may influence the interpretation.

Step 2: Consider repeating the PSA test

The American Urological Association/Society of Urologic Oncology recommends repeating a newly elevated PSA before moving on to a secondary biomarker test, imaging, or biopsy. PSA can return to a lower level on repeat testing, so confirmation may help avoid unnecessary procedures.

The appropriate timing depends on the PSA level, recent procedures, infection, urinary retention, and other clinical factors. Your clinician should determine when a repeat test makes sense.

Step 3: Discuss additional risk assessment

If PSA remains elevated, your clinician may recommend additional evaluation. Depending on the circumstances, this may include:

A digital rectal examination (DRE).
A secondary blood or urine biomarker test.
Prostate MRI.
A prostate cancer risk calculator.
Referral to a urologist.

Not everyone needs all of these tests. The aim is to determine whether the likelihood of clinically significant cancer justifies further investigation.

Step 4: Consider a prostate biopsy if appropriate

A biopsy collects small samples of prostate tissue for examination by a pathologist. It can establish whether cancer is present and provide information about the tumor's grade.

A biopsy may be recommended when the overall risk is concerning, but the decision should account for potential benefits, risks, and alternatives.

A negative biopsy does not always eliminate the possibility of cancer. If concern remains, your clinician may recommend continued monitoring or further evaluation.

What Is the Difference Between PSA and Free PSA?

Most PSA in the blood is found in two forms: PSA attached to proteins and PSA circulating freely.

A total PSA test measures both forms. A percent-free PSA test compares the amount of free PSA with the total PSA level.

The percentage of free PSA tends to be lower in men with prostate cancer than in men without cancer. In selected patients with a borderline total PSA, clinicians may use percent-free PSA to help decide whether a biopsy is warranted.

Other secondary tests, such as the Prostate Health Index (PHI) and 4Kscore, combine additional biomarkers or clinical information to help estimate the likelihood of prostate cancer.

These tests are not necessary for everyone, and their use depends on the patient's circumstances and local clinical practice.

Is PSA Velocity Important?

PSA velocity refers to how quickly PSA rises over time.

Although a rising PSA can be clinically relevant, PSA velocity alone has not consistently shown enough additional value to serve as a standalone screening decision tool. The ACS notes that most doctors do not use PSA velocity by itself to decide whether a man should undergo screening or biopsy.

A series of results can still be useful. Your clinician may consider changes over time alongside your current PSA, age, prostate size, family history, and other risk factors.

Do not assume that every increase means cancer is developing, or that a stable result rules cancer out.

How Often Should You Have a PSA Test?

There is no single testing interval appropriate for every man.

The interval depends on age, risk factors, previous PSA levels, overall health, and the result of shared decision-making with a healthcare provider.

The American Cancer Society recommends discussing the potential benefits and risks of screening at age 50 for men at average risk who are expected to live at least 10 more years. The discussion should occur at age 45 for men at high risk, including Black men and men with a first-degree relative diagnosed with prostate cancer before age 65. Men with more than one first-degree relative diagnosed at an early age may be advised to discuss screening at age 40.

The USPSTF's published recommendation focuses on individualized decision-making for men ages 55–69 and recommends against routine PSA-based screening for men age 70 and older. Because recommendations differ and may be updated, discuss current guidance with your healthcare provider.

Men with urinary symptoms should seek diagnostic evaluation rather than relying only on a routine screening schedule.

Does Medicare Cover a PSA Test?

Yes. Medicare Part B covers eligible prostate cancer screening services, including a PSA blood test once every 12 months for eligible beneficiaries age 50 and older.

Under Medicare's screening benefit, the PSA test is covered without cost-sharing when the applicable requirements are met. A digital rectal examination has different cost-sharing rules. Diagnostic testing ordered because of an abnormal result may also be covered under different rules.

Check the current details on Medicare.gov's prostate cancer screening page and confirm coverage with your provider or plan.

Medicare Advantage plans must cover Medicare-covered preventive services, but network requirements and administrative procedures may differ.

Frequently Asked Questions

Can you have prostate cancer with a normal PSA?

Yes. Some men with prostate cancer have PSA levels below commonly used thresholds. A normal-looking result does not completely rule out cancer, especially when other risk factors or clinical findings are present.

Is a PSA level of 5 ng/mL high?

A PSA of 5 ng/mL is above the commonly used 4 ng/mL threshold, but it does not establish a cancer diagnosis. Its significance depends on age, prostate size, previous results, medications, and other risk factors.

Does an elevated PSA always mean a biopsy is needed?

No. A clinician may first repeat the test or use additional risk assessment, biomarkers, or MRI. A biopsy is considered when the overall clinical assessment indicates that further investigation is appropriate.

Can an enlarged prostate cause a high PSA?

Yes. BPH can increase PSA because the enlarged prostate produces more PSA. However, BPH and prostate cancer can coexist, so an elevated result should be interpreted by a healthcare professional.

Should I be worried if my PSA rises?

A rising PSA deserves context, but it does not automatically mean cancer. Your clinician may review the pattern, repeat the test, and decide whether additional assessment is needed.

Can I lower my PSA naturally?

Do not rely on supplements or lifestyle changes as a substitute for evaluating an elevated PSA. A high result may have several causes, and the appropriate next step depends on the clinical situation. Discuss medicines, supplements, and lifestyle questions with your healthcare provider.

The Bottom Line

The PSA test is an important tool for assessing prostate cancer risk, but it is not a definitive cancer test. PSA levels generally rise with age, and there is no universal cutoff that separates cancer from noncancerous conditions.

A higher result may warrant a repeat test or additional evaluation, while a lower result does not completely exclude cancer. The most appropriate next step depends on personal risk, medical history, medications, and the result itself.

If your PSA is elevated, review it with your healthcare provider before assuming that you have cancer or that you need a biopsy. A careful, individualized assessment can help balance the benefits of detecting clinically significant cancer against the potential harms of unnecessary testing and treatment.

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. PSA results should be interpreted by a qualified healthcare professional who can consider your individual risk factors and medical history.

Source review date: October 11, 2026. PSA information was reviewed against resources from the National Cancer Institute, American Cancer Society, American Urological Association/Society of Urologic Oncology, and Medicare.gov.